Floatz logo

IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER

Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype

National Cancer Institute (NCI)monoclonal_antibodyPhase 2Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
89/ 100

Competitive context

4 Active assets in the Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype cohort.

Asset / SponsorPhaseRating
mt027 car-t cells
T-MAXIMUM Pharmaceutical Inc
Phase 2CCC
Eflornithine
Mayo Clinic
Phase 1/2CCC
ADVICOR COMPONENT NIACIN
AHS Cancer Control Alberta
Phase 1/2CC
LMP744
National Institute of Neurological Disorders and Stroke (NINDS)
Phase 1/2CC
Debio 0123
Debiopharm International SA
Phase 1/2CC

Same molecule, other indications

IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER is also rated in:

plasma cell myelomaDormant
BB
Indicative ·
68 / 100
View asset →
skin squamous cell carcinomaDormant
BB
Indicative ·
66 / 100
View asset →
lung cancerDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →